Anne-sophie S. Chretien

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.

Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.

Journal: Cancer communications (London, England)

Published: November 23, 2025

BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells.

BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells.

Journal: Cell reports

Published: March 12, 2025

Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer.

Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer.

Journal: Cancer immunology research

Published: December 13, 2024

Preoperative lymphocyte signature predicts pancreatic fistula after pancreatoduodenectomy.

Preoperative lymphocyte signature predicts pancreatic fistula after pancreatoduodenectomy.

Journal: Communications medicine

Published: October 19, 2024

Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical Cancer.

Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical Cancer.

Journal: Cancer immunology research

Published: October 09, 2024

CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.

CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.

Journal: Frontiers in immunology

Published: August 28, 2024

A beginner's guide to supervised analysis for mass cytometry data in cancer biology.

A beginner's guide to supervised analysis for mass cytometry data in cancer biology.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: June 10, 2024

Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia.

Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia.

Journal: Blood advances

Published: September 05, 2023

Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells.

Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells.

Journal: Cells

Published: March 26, 2023

CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.

CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.

Journal: Cancer research

Published: February 23, 2023

Artificial intelligence contribution to multi-omic data in the treatment of breast cancers by neoadjuvant chemotherapy

Artificial intelligence contribution to multi-omic data in the treatment of breast cancers by neoadjuvant chemotherapy

Journal: Medecine sciences : M/S

Published: October 11, 2022

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy.

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy.

Journal: Seminars in immunopathology

Published: September 15, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026